tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALNY Stock Latest News

Tenaya Therapeutics enters research collaboration with Alnylam
The FlyTenaya Therapeutics enters research collaboration with Alnylam
11d ago
ALNY
TNYA
Alnylam Grants CEO New Performance-Based Equity Award
PremiumCompany Announcements
Alnylam Grants CEO New Performance-Based Equity Award
11d ago
8K
ALNY
Alnylam’s KARDIA-3 Hypertension Trial Reaches Completion, Raising Key Questions for ALNY Investors
PremiumCompany Announcements
Alnylam’s KARDIA-3 Hypertension Trial Reaches Completion, Raising Key Questions for ALNY Investors
14d ago
ALNY
Balancing Short-Term Amvuttra Headwinds Against Solid TTR Growth: Rationale for Maintaining a Hold Rating
PremiumRatings
Balancing Short-Term Amvuttra Headwinds Against Solid TTR Growth: Rationale for Maintaining a Hold Rating
14d ago
ALNY
Alnylam’s New Phase 1 ALN-4285 Trial: What Early Safety Data Could Mean for ALNY Investors
PremiumCompany Announcements
Alnylam’s New Phase 1 ALN-4285 Trial: What Early Safety Data Could Mean for ALNY Investors
16d ago
ALNY
Alnylam: Strong Amvuttra Outperformance and High-Value Pipeline Optionality Support Buy Rating
PremiumRatingsAlnylam: Strong Amvuttra Outperformance and High-Value Pipeline Optionality Support Buy Rating
27d ago
ALNY
Alnylam price target raised to $429 from $415 at Canaccord
Premium
The Fly
Alnylam price target raised to $429 from $415 at Canaccord
27d ago
ALNY
Alnylam price target raised to $429 from $415 at Canaccord
Premium
The Fly
Alnylam price target raised to $429 from $415 at Canaccord
27d ago
ALNY
Alnylam price target lowered to $249 from $415 at Canaccord
PremiumThe Fly
Alnylam price target lowered to $249 from $415 at Canaccord
27d ago
ALNY
Alnylam upgraded to Buy from Hold at Freedom Capital
PremiumThe Fly
Alnylam upgraded to Buy from Hold at Freedom Capital
27d ago
ALNY
3 ‘Strong Buy’ Stocks to Buy Now, 2/13/2026, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Now, 2/13/2026, According to Top Analysts
1M ago
ALNY
DDOG
Alnylam price target lowered to $360 from $408 at Morgan Stanley
PremiumThe Fly
Alnylam price target lowered to $360 from $408 at Morgan Stanley
1M ago
ALNY
Alnylam price target lowered to $451 from $491 at Bernstein
PremiumThe FlyAlnylam price target lowered to $451 from $491 at Bernstein
1M ago
ALNY
Alnylam price target lowered to $425 from $475 at Chardan
Premium
The Fly
Alnylam price target lowered to $425 from $475 at Chardan
1M ago
ALNY
Execution Risks Loom as Alnylam Races to Scale Global Operations for AMVUTTRA and 2030 Growth Ambitions
Premium
Company Announcements
Execution Risks Loom as Alnylam Races to Scale Global Operations for AMVUTTRA and 2030 Growth Ambitions
1M ago
ALNY
Alnylam Pharmaceuticals: Amvuttra-Driven Profitability Inflection Supports Long-Term Growth and Buy Rating
PremiumRatings
Alnylam Pharmaceuticals: Amvuttra-Driven Profitability Inflection Supports Long-Term Growth and Buy Rating
1M ago
ALNY
Alnylam Pharmaceuticals Projects Powerful Growth After Breakout Year
PremiumCompany Announcements
Alnylam Pharmaceuticals Projects Powerful Growth After Breakout Year
1M ago
ALNY
Alnylam: ATTR Franchise Momentum and Strategic Investment Support Durable Growth and Buy Rating
PremiumRatings
Alnylam: ATTR Franchise Momentum and Strategic Investment Support Durable Growth and Buy Rating
1M ago
ALNY
Alnylam price target lowered to $444 from $508 at Stifel
PremiumThe Fly
Alnylam price target lowered to $444 from $508 at Stifel
1M ago
ALNY
Alnylam: Profitability Milestone and ATTR Momentum Underpin Durable Double-Digit Growth and Buy Rating
PremiumRatingsAlnylam: Profitability Milestone and ATTR Momentum Underpin Durable Double-Digit Growth and Buy Rating
1M ago
ALNY
Alnylam sees FY26 revenue $4.9B-$5.3B, consensus $5.55B
Premium
The Fly
Alnylam sees FY26 revenue $4.9B-$5.3B, consensus $5.55B
1M ago
ALNY
Alnylam reports Q4 EPS $1.25, consensus $1.50
Premium
The Fly
Alnylam reports Q4 EPS $1.25, consensus $1.50
1M ago
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >